Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1925 of 5804
-
Can special lenses put the brakes on childhood myopia?
Disease control TerminatedThis is a mono-centre, prospective, one-arm, unmask clinical trial to evaluate the effectiveness of test lens in slowing myopia progression with respect to axial length elongation compared to a single vision spectacle lens from the historical control group of another clinical tri…
Phase: NA • Sponsor: Essilor International • Aim: Disease control
Last updated Jul 23, 2026 00:00 UTC
-
New lens implant tackles cataracts and astigmatism in one surgery
Disease control CompletedThe objectives of the clinical investigation are to determine the safety and performance of the RayOne EMV Toric (Model RAO210T) following unilateral implantation and approximately 6 months (120 to 180 days) of post-operative assessment, as a randomized comparison to aspheric mon…
Phase: NA • Sponsor: Rayner Intraocular Lenses Limited • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC
-
New hope for psoriasis sufferers: drug targets Hard-to-Treat areas
Disease control CompletedPsoriasis (PsO) is a chronic disease characterized by marked inflammation of the skin that results in thick, red, scaly plaques. This study will assess how safe and effective risankizumab is in adult participants with moderate to severe genital psoriasis or moderate to severe sca…
Phase: PHASE4 • Sponsor: AbbVie • Aim: Disease control
Last updated Jun 27, 2026 09:08 UTC
-
New study tracks how a skin disease drug works in everyday life
Disease control OngoingThe purpose of this observational, prospective, non-interventional, multicenter, open-label, single arm study in Hidradenitis suppurativa (HS) is to assess the treatment pattern of secukinumab in a flexible dosing regimen and decision influencing factors for flexible dosing in a …
Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Jul 22, 2026 00:00 UTC
-
Can a steroid help seniors regain muscle? new trial investigates
Disease control Recruiting nowThis is a single-center, prospective, randomized, double-blind (pharmacotherapy), placebo-controlled, and comprehensive physiotherapy and nutritional intervention phase II clinical trial to determine the usefulness of nandrolone decanoate in a new indication (sarcopenia). Patien…
Phase: PHASE2 • Sponsor: National Institute of Geriatrics, Rheumatology and Rehabilitation, Poland • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC
-
New experimental flu vaccine aims to outsmart the flu virus
⭐️ VACCINE ⭐️ CompletedBackground: Influenza (flu) virus causes 3 to 5 million cases of severe illness and up to 650,000 deaths per year worldwide. Current vaccines work well against single strains of flu virus. But no single vaccine works well against all flu viruses that can cause illness. Objectiv…
Phase: PHASE1 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: ⭐️ VACCINE ⭐️
Last updated Jul 15, 2026 00:00 UTC
-
Could a sleep drug help kids with autism rest better?
Symptom relief Recruiting nowThe purpose of this study is to examine the effect of suvorexant on sleep in children and adolescents with Autism Spectrum Disorder (ASD). Suvorexant is a selective, dual orexin receptor antagonist (DORA) used for the treatment of sleep onset difficulties and/or sleep maintenance…
Phase: PHASE2 • Sponsor: Stanford University • Aim: Symptom relief
Last updated Jun 27, 2026 12:00 UTC
-
New daily pill could help control blood sugar in type 2 diabetes
Disease control CompletedThe main purpose of this study is to determine safety and efficacy of orforglipron compared with placebo in adult participants with type 2 diabetes and inadequate glycemic control with diet and exercise alone. The study will last approximately 54 weeks.
Phase: PHASE3 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Acupuncture vs. pills: which works better for slipped discs?
Symptom relief Recruiting nowThis is a randomized controlled study comparing non-pharmacological treatment to proactive pharmacological treatment for patient with non-acute lumbar disc herniation with moderate or higher levels of pain. The study involves 200 adult patients aged 19-69, with 50 patients from e…
Phase: NA • Sponsor: Jaseng Medical Foundation • Aim: Symptom relief
Last updated Jun 26, 2026 15:50 UTC
-
New strategy aims to boost addiction treatment and curb HIV in central asia
Disease control Recruiting nowCentral Asia (CA) represents the most rapidly growing HIV epidemic region worldwide, concentrated in people who inject drugs (PWID) and their sexual partners, and scaling up opioid agonist therapies (OAT) in this region is the most cost-effective strategy to prevent new HIV infec…
Phase: NA • Sponsor: Yale University • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC
-
New hope for tough blood cancers? early trial launches
Disease control Recruiting nowThis is a Phase 1, open-label, dose-escalation study to evaluate the safety, PK, PD and immunogenicity of CC312 following intravenous doses of CC312 in patients with relapsed and refractory (r/r) CD19 expressing B-cell non-Hodgkin lymphoma and B-cell lymphocytic leukemia.
Phase: PHASE1 • Sponsor: CytoCares Inc • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC
-
New DNA test could speed up pneumonia diagnosis in ICU patients
Diagnosis OngoingIn this randomized controlled trial, we aim to evaluate the efficacy of incorporating mNGS in the management of pneumonia on efficiency and accuracy of causative pathogen identification, proportion of participants with effective antimicrobial therapy, length of hospitalization, a…
Phase: NA • Sponsor: National Taiwan University Hospital • Aim: Diagnosis
Last updated Jun 27, 2026 07:58 UTC
-
New eye implant aims to stop vision loss from diabetes
Disease control CompletedThis is a Phase 2a, randomized, single-masked (participant), sham controlled clinical study.
Phase: PHASE2 • Sponsor: Perfuse Therapeutics, Inc. • Aim: Disease control
Last updated Jun 27, 2026 13:02 UTC
-
Keyhole vs. open surgery: which is safer for pancreatic cancer?
Disease control CompletedLaparoscopic pancreaticoduodenectomy (LPD), a surgical option for nonpancreatic periampullary adenocarcinoma (NPPA), is a complex procedure that has become increasing popular. However, there is no consensus as to whether this technique should be performed routinely. Our aim was t…
Phase: NA • Sponsor: Theodor Bilharz Research Institute • Aim: Disease control
Last updated Jun 27, 2026 09:08 UTC
-
New heart stent under review in 3,000-Patient study
Disease control Recruiting nowInternational, Multicenter, prospective, non-randomized, post-market clinical follow-up (PMCF) study to confirm and support the clinical safety and performance of Coroflex® ISAR NEO coronary stent system to meet EU Medical Device regulation (MDR) requirements in all the CONSECUTI…
Sponsor: Fundación EPIC • Aim: Disease control
Last updated Jun 27, 2026 12:28 UTC
-
Simple wound treatment slashes Post-Surgery complications in breast cancer patients
Disease control CompletedSeroma (a collection of fluid under the skin) is a common problem after breast cancer surgery, especially after modified radical mastectomy (MRM), where lymph nodes from the armpit are also removed. This can happen because surgery may damage small blood and lymph vessels. Doctors…
Phase: NA • Sponsor: Noor ul Ain • Aim: Disease control
Last updated Jun 27, 2026 09:08 UTC
-
New contact lenses aim to slow nearsightedness in kids
Disease control OngoingTo compare the rate of myopia progression of contact lenses utilising S.T.O.P.® technology against MiSight® contact lenses.
Phase: NA • Sponsor: nthalmic Pty Ltd • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New portable MRI could spot fatty liver in minutes
Diagnosis OngoingThis research study is being conducted to find out more about techniques to non-invasively evaluate liver disease. The investigators are testing a new technology to evaluate the liver (LiverScope®), and they will compare it to other methods to evaluate the liver, including advanc…
Sponsor: University of California, San Diego • Aim: Diagnosis
Last updated Jun 27, 2026 07:55 UTC
-
Behavioral therapy may beat medication for Hair-Pulling and Skin-Picking
Symptom relief OngoingThe goal of the proposed study is to compare the efficacy of behavioral treatment (BT) to memantine, a psychopharmacological agent, for BFRBs. 28 subjects with trichotillomania (TTM) or skin picking disorder (SPD) will receive 8 weeks of memantine treatment, followed by 8 weeks o…
Phase: PHASE2, PHASE3 • Sponsor: University of Chicago • Aim: Symptom relief
Last updated Jul 09, 2026 00:00 UTC
-
New study aims to improve cervical cancer detection in HIV-Positive women
Diagnosis OngoingCervical cancer is a relatively common cancer among women living with human immunodeficiency virus (HIV). This study will test women for human papillomavirus (HPV) infection of the cervix. The main purpose of this study is to determine the best way to test for damaged areas of th…
Phase: NA • Sponsor: Weill Medical College of Cornell University • Aim: Diagnosis
Last updated Jun 28, 2026 00:00 UTC